Skip to main content

Transcelerate Biopharma Inc

West Conshohocken, Pennsylvania·EIN 46-0886344·NTEE H99 · Medical Research·501(c)(6)·Filing year 2024

Transcelerate Biopharma Inc's highest-paid officer, the CEO, was reported at $1,104,805 for 2024 (IRS Form 990), including base pay and other compensation. Reported CEO pay ranged from $1,104,805 to $1,105,683 between 2023 and 2024.

Total revenue
$38.6M
Total assets
$55.3M
Total expenses
$31.7M
Reported officers
34

How Transcelerate Biopharma Inc’s pay compares

Compared with Medical Research organizations of similar size nationwide.

There were too few similar organizations to compare with, so this group goes beyond Pennsylvania.

Above peers

Most of the roles Transcelerate Biopharma Inc reports are paid above the middle half of what these Medical Research organizations pay for the same roles.

Show how each role compares

From the officer pay Transcelerate Biopharma Inc reported on its latest IRS Form 990.

THE ORGANIZATION'S MISSION IS TO COLLABORATE ACROSS THE GLOBAL BIOPHARMACEUTICAL R&D COMMUNITY TO IDENTIFY, DESIGN AND FACILITATE IMPLEMENTATION OF SOLUTIONS DESIGNED TO DRIVE THE EFFICIENT, EFFECTIVE AND HIGH QUALITY DELIVERY OF NEW MEDICINES.

Executive compensation, broken down

Form 990 · Part VII & Schedule J · 7 reported individuals · Filing year 2024

Percentile bands compare each position's total pay with the same role at Medical Research organizations of similar size nationwide. There were too few similar organizations to compare with, so this group goes beyond Pennsylvania.

CEO
Above 90th percentile
$1.1M
Base
$786k
Bonus
$276k
Other
—
Benefits
$29k
COO
75th to 90th percentile
$636k
Base
$442k
Bonus
$140k
Other
—
Benefits
$40k
Vp, Global Communications & Engagement
Board Vice President
$506k
Base
$342k
Bonus
$119k
Other
—
Benefits
$31k
Vp, Portfolio Management
Board Vice President
$471k
Base
$310k
Bonus
$107k
Other
—
Benefits
$53k
Vp, Portfolio Management
Board Vice President
$456k
Base
$300k
Bonus
$89k
Other
—
Benefits
$59k
Head of Finance & Administration
Highest Compensated Employee
Above 75th percentileOn the typical range for this role
$445k
Base
$269k
Bonus
$129k
Other
—
Benefits
$33k
Exec. Portfolio Director
Highest Compensated Employee
Median to 75th percentileOn the typical range for this role
$430k
Base
$305k
Bonus
$91k
Other
—
Benefits
$20k

Plus 27 unpaid individuals.

Browse compensation in Medical Research →

Top pay as a share of expenses

In 2024, the highest total compensation at Transcelerate Biopharma Inc equaled 3% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2024)
3%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,115 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Down 56%
from 2023

From $2.5M in 2023 to $1.1M in 2024.

$2.5M
2023
$1.1M
2024
Pay for the position

Chief Executive Officer pay held roughly steady from 2023 to 2024, while revenue rose 13%.

$1.1M in 2023 to $1.1M in 2024.
  • Chief Operating Officer pay rose 98% from 2023 to 2024.
  • Board Vice President pay fell 18% from 2023 to 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Common questions about Transcelerate Biopharma Inc

What does the Chief Executive Officer of Transcelerate Biopharma Inc earn?

In 2024, the Chief Executive Officer of Transcelerate Biopharma Inc received $1,104,805 in total compensation. This pay is in the top 10% for Chief Executive Officer roles among Medical Research organizations of similar size nationwide: at least 9 in 10 comparable filings report less. Based on IRS Form 990 data.

How does Chief Executive Officer pay at Transcelerate Biopharma Inc compare with similar nonprofits?

Compared with the same role at Medical Research organizations of similar size nationwide, the 2024 pay of the Chief Executive Officer at Transcelerate Biopharma Inc falls in the top 10%. In 2024, the highest total compensation at Transcelerate Biopharma Inc equaled 3% of the organization's total expenses. The median for medical research organizations is 10%.

What are Transcelerate Biopharma Inc's revenue and expenses?

In 2024, Transcelerate Biopharma Inc reported $38.6M in total revenue and $31.7M in total expenses on its IRS Form 990.